SAN

76.26

-1.73%↓

UCB

250.1

-3.1%↓

SHL.DE

40.38

-0.02%↓

ARGX

620.4

-1.02%↓

PHIA

24.97

-2.19%↓

SAN

76.26

-1.73%↓

UCB

250.1

-3.1%↓

SHL.DE

40.38

-0.02%↓

ARGX

620.4

-1.02%↓

PHIA

24.97

-2.19%↓

SAN

76.26

-1.73%↓

UCB

250.1

-3.1%↓

SHL.DE

40.38

-0.02%↓

ARGX

620.4

-1.02%↓

PHIA

24.97

-2.19%↓

SAN

76.26

-1.73%↓

UCB

250.1

-3.1%↓

SHL.DE

40.38

-0.02%↓

ARGX

620.4

-1.02%↓

PHIA

24.97

-2.19%↓

SAN

76.26

-1.73%↓

UCB

250.1

-3.1%↓

SHL.DE

40.38

-0.02%↓

ARGX

620.4

-1.02%↓

PHIA

24.97

-2.19%↓

Search

Gerresheimer AG

Gesloten

SectorGezondheidszorg

18.18 2.36

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

17.89

Max

18.87

Belangrijke statistieken

By Trading Economics

Inkomsten

-30M

-13M

Verkoop

-40M

561M

K/W

Sectorgemiddelde

23.706

66.845

Dividendrendement

0.24

Winstmarge

-2.265

Werknemers

13,535

EBITDA

-45M

74M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+44.04% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.24%

2.25%

Volgende Winsten

13 mrt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-366M

557M

Vorige openingsprijs

15.82

Vorige sluitingsprijs

18.18

Nieuwssentiment

By Acuity

8%

92%

7 / 351 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Weak Bullish Evidence

Gerresheimer AG Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

4 apr 2025, 10:15 UTC

Belangrijke Marktbewegers
Acquisities, Fusies, Overnames

Gerresheimer Shares Fall After Report That KKR Exited Consortium Seeking Bid

4 apr 2025, 09:39 UTC

Acquisities, Fusies, Overnames

KKR Drops Out of Consortium Attempting Gerresheimer Takeover, Bloomberg Says, Citing Sources

Peer Vergelijking

Prijswijziging

Gerresheimer AG Prognose

Koersdoel

By TipRanks

44.04% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 26.1 EUR  44.04%

Hoogste 46 EUR

Laagste 12.9 EUR

Gebaseerd op 10 Wall Street-analisten die 12-maands prijsdoelen bieden voor Gerresheimer AG - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

10 ratings

3

Buy

3

Hold

4

Sell

Technische score

By Trading Central

60.1 / 60.95Steun & Weerstand

Korte Termijn

Weak Bullish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

7 / 351 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.
help-icon Live chat